Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Virax Biolabs Group Ltd - Ordinary Shares - Class A market cap is $1.55M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week high is $5.45 as of April 24, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Virax Biolabs Group Ltd - Ordinary Shares - Class A 52 week low is $0.6133 as of April 24, 2024.
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price today is $0.6636.
Virax Biolabs Group Ltd - Ordinary Shares - Class A stock price yesterday was $0.658.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Virax Biolabs Group Ltd - Ordinary Shares - Class A’s P/E ratio is -0.16.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Virax Biolabs Group Ltd - Ordinary Shares - Class A P/B ratio is 0.1882.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Virax Biolabs Group Ltd - Ordinary Shares - Class A's EBITDA is -0.09.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Virax Biolabs Group Ltd - Ordinary Shares - Class A 50-day moving average is $0.8219.
Virax Biolabs Group Ltd - Ordinary Shares - Class A has 11 employees.